RTW BIO completes investment in Arix Bioscience ahead of merger

LONDON, UK: RTW BIO, a biopharmaceutical and medical technology investment company, has completed its investment in Arix Bioscience, a life sciences venture capital firm, ahead of their planned merger. RTW BIO has acquired a 25.5% stake in Arix from Acacia Research Corporation for US$57 million, or £1.37 per share, and has committed to vote in…

Kain Capital completes investment in MDLand

Kain Capital completes investment in MDLand

NEW YORK: Kain Capital LLC has completed its investment in MDLand, a comprehensive technology platform designed to unify and modernize the healthcare industry’s antiquated and disjointed systems, a news release siad. MDLand equips managed care service providers with the technology needed to work more efficiently and profitably, while improving patient outcomes and generating quality of…